サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1611167

腱炎治療の世界市場規模、シェア、動向分析レポート：治療別、症状別、地域別、セグメント別予測（2025年～2030年）

Tendonitis Treatment Market Size, Share & Trends Analysis Report By Treatment, By Condition, By Region, And Segment Forecasts, 2025 - 2030

出版日
ページ情報
英文 150 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=145.28円
腱炎治療の世界市場規模、シェア、動向分析レポート：治療別、症状別、地域別、セグメント別予測（2025年～2030年）
出版日: 2024年11月26日
発行: Grand View Research
ページ情報: 英文 150 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

腱炎治療市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の腱炎治療の市場規模は、2025年～2030年に3.1%のCAGRを記録し、2030年に2,818億米ドルに達する見込みです。

身体活動やスポーツ活動への参加の増加は、スポーツ関連傷害の発症率の上昇に直接影響しています。さらに、労働災害の発生率の上昇は、予測期間中の業界の発展と成長に貢献すると予測されています。また、世界の高齢者人口の増加は、骨障害、糖尿病、関節炎、変形性関節症、骨粗鬆症、または腱炎にかかりやすくなっています。腱炎を管理する先進的な治療法や技術を常に革新している市場参入企業も、市場成長に貢献しています。

投資の増加、業界との提携、政府による支援の増加なども、市場成長を加速する主な要因です。過去数年にわたり、スポーツ選手の健康管理において怪我を予防するため、積極的な治療法から予防的な治療法への移行が進んでいます。Standard Children's Healthによると、2018年には米国でスポーツ活動に参加している青少年3,000万人のうち約350万人がスポーツ関連の怪我をしています。調査によると、米国では年間約77万5,000人の青少年がスポーツ関連傷害の治療や処置を受けています。

COVID-19の大流行や各国でのロックダウンや旅行制限の実施中、腱炎治療件数の減少により業界の成長はマイナスの影響を受けました。スポーツイベントの延期や中止は、スポーツ関連傷害の発生率の低下につながり、その結果、市場の業績が低下しました。2021年には、療法セグメントが最大のシェアを占め、予測期間中に大きく成長すると予測されています。これは、非侵襲的な治療方法が好まれるためです。治療管理の第一線は理学療法であり、かなりの成長が見込まれます。

アキレス腱炎セグメントは2022年に業界を支配しました。この成長は、スポーツ選手のスポーツ関連傷害の発生率が増加していることに起因しています。調査によると、アキレス腱炎の発生率は人口10万人当たり5～10人です。北米が2022年に最大のシェアを占めたのは、有名メーカーやディストリビューターの存在、スポーツ関連や外傷の発生率の増加、さまざまな療法や外科的処置の利用可能性に関する認知度の高まりによるものです。

腱炎治療市場レポートのハイライト

  • 治療別では、療法セグメントが2024年に最大の収益シェアを占め、腱炎治療産業を支配しました。非侵襲的治療に対する腱炎患者の嗜好の高まりが、このセグメントの成長に寄与しています。
  • 症状別では、アキレス腱炎セグメントが2024年の売上高シェア48.8％で市場を独占しました。同セグメントは、特にアスリートや反復的な身体活動に従事する人々の間でアキレス腱炎の発症率が高いことから、市場を独占しています。
  • 北米の腱炎治療市場は、2024年に42.2％の収益シェアで優位を占めました。同地域で腱炎の手術件数が増加していること、消費者の可処分所得水準が上昇していることなどが、同地域の成長に寄与しています。
  • アジア太平洋は、急速な高齢化、筋骨格系の健康に対する意識の高まり、ヘルスケア投資の増加などの要因が重なり、予測期間中、腱炎治療市場で最も速い成長が見込まれています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 腱炎治療市場の変数、動向、範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 補助市場の見通し
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • 規制の枠組み
  • 腱炎治療：市場分析ツール
    • 業界分析：ポーターのファイブフォース分析
    • PESTLE分析

第4章 腱炎治療市場セグメント分析：治療別（2018年～2030年）

  • 定義と範囲
  • 治療の市場シェア分析（2024年・2030年）
  • セグメントダッシュボード
  • 世界の腱炎治療市場：治療別（2018年～2030年）
  • 療法
    • 療法の市場推計・予測（2018年～2030年）
    • 温熱療法と冷却療法
    • 理学療法
    • 衝撃波療法
  • 手術
    • 手術の市場推計・予測（2018年～2030年）

第5章 腱炎治療市場セグメント分析：症状別（2018年～2030年）

  • 定義と範囲
  • 症状の市場シェア分析（2024年・2030年）
  • セグメントダッシュボード
  • 世界の腱炎治療市場：症状別（2018年～2030年）
  • テニス肘
    • テニス肘の市場推計・予測（2018年～2030年）
  • ゴルフ肘
    • ゴルフ肘の市場推計・予測（2018年～2030年）
  • 野球肘
    • 野球肘の市場推計・予測（2018年～2030年）
  • ジャンパー膝
    • ジャンパー膝の市場推計・予測（2018年～2030年）
  • 水泳肩
    • 水泳肩の市場推計・予測（2018年～2030年）
  • アキレス腱炎
    • アキレス腱炎の市場推計・予測（2018年～2030年）

第6章 腱炎治療市場セグメント分析：地域別（2018年～2030年）

  • 地域別市場シェア分析（2024年・2030年）
  • 地域市場ダッシュボード
  • 地域市場のスナップショット
  • 腱炎治療の市場シェア：地域別（2024年・2030年）
  • 北米
    • 北米の腱炎治療市場（2018年～2030年）
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 欧州の腱炎治療市場（2018年～2030年）
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • ノルウェー
    • スウェーデン
    • デンマーク
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • オーストラリア
    • 韓国
    • タイ
  • ラテンアメリカ
    • ブラジル
    • アルゼンチン
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第7章 競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • 企業分類
  • 企業プロファイル
    • Merck and Co., Inc.
    • Bayer AG
    • AstraZeneca
    • Boehringer Ingelheim Pharmaceuticals, Inc.
    • Abbott
    • Pfizer
    • GlaxoSmithKline PLC
    • Almatica Pharma, Inc.
    • Teva Pharmaceuticals Industries
図表

List of Tables

  • Table 1. List of secondary sources
  • Table 2. List of abbreviation
  • Table 3. Product pipeline/clinical stage
  • Table 4. List of emerging companies in tendonitis treatment market
  • Table 5. North America Tendonitis Treatment market, by country, 2018 - 2030 (USD Million)
  • Table 6. North America Tendonitis Treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 7. North America Tendonitis Treatment market, by condition, 2018 - 2030 (USD Million)
  • Table 8. U.S. Tendonitis Treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 9. U.S. Tendonitis Treatment market, by condition, 2018 - 2030 (USD Million)
  • Table 10. Canada Tendonitis Treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 11. Canada Tendonitis Treatment market, by condition, 2018 - 2030 (USD Million)
  • Table 12. Mexico Tendonitis Treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 13. Mexico Tendonitis Treatment market, by condition, 2018 - 2030 (USD Million)
  • Table 14. Europe Tendonitis Treatment market, by country, 2018 - 2030 (USD Million)
  • Table 15. Europe Tendonitis Treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 16. Europe Tendonitis Treatment market, by condition, 2018 - 2030 (USD Million)
  • Table 17. U.K. Tendonitis Treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 18. U.K. Tendonitis Treatment market, by condition, 2018 - 2030 (USD Million)
  • Table 19. Germany Tendonitis Treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 20. Germany Tendonitis Treatment market, by condition, 2018 - 2030 (USD Million)
  • Table 21. France Tendonitis Treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 22. France Tendonitis Treatment market, by condition, 2018 - 2030 (USD Million)
  • Table 23. Spain Tendonitis Treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 24. Spain Tendonitis Treatment market, by condition, 2018 - 2030 (USD Million)
  • Table 25. Italy Tendonitis Treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 26. Italy Tendonitis Treatment market, by condition, 2018 - 2030 (USD Million)
  • Table 27. Norway Tendonitis Treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 28. Norway Tendonitis Treatment market, by condition, 2018 - 2030 (USD Million)
  • Table 29. Denmark Tendonitis Treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 30. Denmark Tendonitis Treatment market, by condition, 2018 - 2030 (USD Million)
  • Table 31. Sweden Tendonitis Treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 32. Sweden Tendonitis Treatment market, by condition, 2018 - 2030 (USD Million)
  • Table 33. Asia Pacific Tendonitis Treatment market, by country, 2018 - 2030 (USD Million)
  • Table 34. Asia Pacific Tendonitis Treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 35. Asia Pacific Tendonitis Treatment market, by condition, 2018 - 2030 (USD Million)
  • Table 36. China Tendonitis Treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 37. China Tendonitis Treatment market, by condition, 2018 - 2030 (USD Million)
  • Table 38. Japan Tendonitis Treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 39. Japan Tendonitis Treatment market, by condition, 2018 - 2030 (USD Million)
  • Table 40. India Tendonitis Treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 41. India Tendonitis Treatment market, by condition, 2018 - 2030 (USD Million)
  • Table 42. Australia Tendonitis Treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 43. Australia Tendonitis Treatment market, by condition, 2018 - 2030 (USD Million)
  • Table 44. South Korea Tendonitis Treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 45. South Korea Tendonitis Treatment market, by condition, 2018 - 2030 (USD Million)
  • Table 46. Thailand Tendonitis Treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 47. Thailand Tendonitis Treatment market, by condition, 2018 - 2030 (USD Million)
  • Table 48. Latin America Tendonitis Treatment market, by country, 2018 - 2030 (USD Million)
  • Table 49. Latin America Tendonitis Treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 50. Latin America Tendonitis Treatment market, by condition, 2018 - 2030 (USD Million
  • Table 51. Brazil Tendonitis Treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 52. Brazil Tendonitis Treatment market, by condition, 2018 - 2030 (USD Million)
  • Table 53. Argentina Tendonitis Treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 54. Argentina Tendonitis Treatment market, by condition, 2018 - 2030 (USD Million)
  • Table 55. MEA Tendonitis Treatment market, by country, 2018 - 2030 (USD Million)
  • Table 56. MEA Tendonitis Treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 57. MEA Tendonitis Treatment market, by condition, 2018 - 2030 (USD Million)
  • Table 58. South Africa Tendonitis Treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 59. South Africa Tendonitis Treatment market, by condition, 2018 - 2030 (USD Million)
  • Table 60. Saudi Arabia Tendonitis Treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 61. Saudi Arabia Tendonitis Treatment market, by condition, 2018 - 2030 (USD Million)
  • Table 62. UAE Tendonitis Treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 63. UAE Tendonitis Treatment market, by condition, 2018 - 2030 (USD Million)
  • Table 64. Kuwait Tendonitis Treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 65. Kuwait Tendonitis Treatment market, by condition, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Commodity Flow Analysis
  • Fig. 9 Volume Price Analysis
  • Fig. 10 Tendonitis Treatment Market snapshot (2022)
  • Fig. 11 Tendonitis Treatment Market segmentation
  • Fig. 12 Market trends and outlook
  • Fig. 13 Parent market outlook
  • Fig. 14 Related/ancillary market outlook
  • Fig. 15 Market driver relevance analysis (Current & future impact)
  • Fig. 16 Market restraint relevance analysis (Current & future impact)
  • Fig. 17 Tendonitis Treatment Market, treatment outlook: key takeaways (USD Million)
  • Fig. 18 Tendonitis Treatment Market: treatment movement analysis, 2022 & 2030 (USD Million)
  • Fig. 19 Therapy Treatment Market 2018 - 2030 (USD Million)
  • Fig. 20 Hot and Cold Treatment Market 2018 - 2030 (USD Million)
  • Fig. 21 Physical Therapy Treatment Market 2018 - 2030 (USD Million)
  • Fig. 22 Shockwave Therapy Treatment Market 2018 - 2030 (USD Million)
  • Fig. 23 Surgery Treatment Market 2018 - 2030 (USD Million)
  • Fig. 24 Tendonitis Treatment Market, Condition outlook: key takeaways (USD Million)
  • Fig. 25 Tendonitis Treatment Market: Condition movement analysis, 2022 & 2030 (USD Million)
  • Fig. 26 Tennis Elbow market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Golfer's Elbow market estimates and forecasts, 2018 - 2030 (USD Million
  • Fig. 28 Pitcher's Elbow market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Jumper's Knee market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Swimmer's Shoulder market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Achilles Tendonitis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Tendonitis Treatment Market, regional marketplace: Key takeaways (USD Million)
  • Fig. 33 Tendonitis Treatment Market: regional movement analysis, 2022 & 2030 (USD Million)
  • Fig. 34 North America Tendonitis Treatment Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 U.S. Tendonitis Treatment Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Canada Tendonitis Treatment Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Mexico Tendonitis Treatment Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Europe Tendonitis Treatment Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Germany Tendonitis Treatment Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 U.K. Tendonitis Treatment Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 France Tendonitis Treatment Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Spain Tendonitis Treatment Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Italy Tendonitis Treatment Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Sweden Tendonitis Treatment Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Denmark Tendonitis Treatment Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Norway Tendonitis Treatment Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Asia Pacific Tendonitis Treatment Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Japan Tendonitis Treatment Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 China Tendonitis Treatment Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 India Tendonitis Treatment Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Australia Tendonitis Treatment Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 South Korea Tendonitis Treatment Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Thailand Tendonitis Treatment Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Latin America Tendonitis Treatment Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Brazil Tendonitis Treatment Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Argentina Tendonitis Treatment Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 MEA Tendonitis Treatment Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 South Africa Tendonitis Treatment Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Saudi Arabia Tendonitis Treatment Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 UAE Tendonitis Treatment Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Kuwait Tendonitis Treatment Market estimates and forecasts, 2018 - 2030 (USD Million)
目次
Product Code: GVR-4-68039-530-4

Tendonitis Treatment Market Growth & Trends:

The global tendonitis treatment market size is expected to reach USD 281.8 billion by 2030, registering a CAGR of 3.1% from 2025 to 2030, according to a new report by Grand View Research, Inc. Growing participation in physical and sporting activities, directly influences the rise in prevalence of sports-related injuries. In addition, the rising incidence of occupational injuries is anticipated to contribute to the development and growth of the industry over the forecast period. The growing global geriatric population is susceptible to bone disorders, diabetes, arthritis, osteoarthritis, osteoporosis, or tendonitis. Industry participants that are constantly innovating advanced therapies and technologies in managing tendonitis are also contributing to the market growth.

Growing investments, industry collaborations, and increasing favorable government support are other key factors accelerating market growth. Over the past years, there has been a transition from proactive to preventive therapies in managing the health of sportspersons in preventing injuries. According to Standard Children's Health, in 2018, approximately 3.5 million out of 30 million adolescents participating in sporting activities in the U.S. incur sports-related injuries. As per studies, annually, around 775,000 adolescents receive therapies and treatments for sports-related injuries in the U.S. Major players are expanding their business footprint in both developed and emerging economies through product innovation and strengthening their distribution cycles.

During the COVID-19 pandemic and enforced lockdowns and travel restrictions imposed across countries, the industry growth was negatively impacted owing to a decline in the number of tendonitis treatment procedures. Postponement and cancellation of sporting events led to a decline in the incidence of sports-related injuries, thereby, resulting in a decline in the business performance of the market. In 2021, the therapy segment accounted for the largest share and is anticipated to grow significantly over the forecast period. This is owing to the high preference for non-invasive treatment procedures. The first line of treatment management is physical therapy, which is expected to witness considerable growth.

The Achilles tendonitis segment dominated the industry in 2022. This growth can be attributed to the growing incidence of sports-related injuries in sports players. As per studies, the incidence rate of Achilles tendonitis ranges between 5 to 10 individuals per 100,000 people. North America accounted for the largest share in 2022 owing to the presence of renowned manufacturers and distributors, growing incidence of sports-related & trauma injuries, and rising awareness about the availability of various therapies & surgical procedures.

Tendonitis Treatment Market Report Highlights:

  • By treatment, the therapy segment dominated the tendonitis treatment industry with the largest revenue share in 2024. The increasing preference of patients with tendonitis for non-invasive treatments contributes to segment growth.
  • By condition, the Achilles tendonitis segment dominated the market with a revenue share of 48.8% in 2024. The segment dominated the market due to the high incidence of Achilles tendonitis condition, particularly among athletes and individuals engaged in repetitive physical activities.
  • North America tendonitis treatment market dominated with a revenue share of 42.2% in 2024. A growing number of surgeries performed for tendonitis in the region and increasing consumer disposable income levels are among the few factors that contribute to the region's growth.
  • The Asia Pacific region is expected to witness the fastest growth in the tendonitis treatment market over the forecast period, driven by a combination of factors such as a large and rapidly aging population, increased awareness about musculoskeletal health, and rising healthcare investments.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Segment scope
    • 1.1.2. Regional scope
    • 1.1.3. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. Research Assumptions
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Condition outlook
    • 2.2.2. Treatment outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Tendonitis Treatment Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
  • 3.3. Regulatory Framework
  • 3.4. Tendonitis Treatment: Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
    • 3.4.2. PESTLE Analysis

Chapter 4. Tendonitis Treatment Market Segment Analysis, By Treatment, 2018 - 2030 (USD Million)

  • 4.1. Definition and Scope
  • 4.2. Treatment Market Share Analysis, 2024 & 2030
  • 4.3. Segment Dashboard
  • 4.4. Global Tendonitis Treatment Market, by Treatment, 2018 to 2030
  • 4.5. Therapy
    • 4.5.1. Therapy market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.5.2. Hot and Cold Therapy
      • 4.5.2.1. Hot and Cold Therapy market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.5.3. Physical Therapy
      • 4.5.3.1. Physical therapy market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.5.4. Shockwave Therapy
      • 4.5.4.1. Shockwave Therapy market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.6. Surgery
    • 4.6.1. Surgery market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Tendonitis Treatment Market Segment Analysis, By Condition, 2018 - 2030 (USD Million)

  • 5.1. Definition and Scope
  • 5.2. Condition Market Share Analysis, 2024 & 2030
  • 5.3. Segment Dashboard
  • 5.4. Global Tendonitis Treatment Market, by Condition, 2018 to 2030
  • 5.5. Tennis elbow
    • 5.5.1. Tennis elbow market estimates and forecasts, 2018 to 2030 (USD million)
  • 5.6. Golfer's elbow
    • 5.6.1. Golfer's elbow market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.7. Pitcher's elbow
    • 5.7.1. Pitcher's elbow market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.8. Jumper's Knee
    • 5.8.1. Jumper's Knee market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.9. Swimmer's shoulder
    • 5.9.1. Swimmer's shoulder market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.10. Achilles Tendonitis
    • 5.10.1. Achilles tendonitis market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Tendonitis Treatment Market Segment Analysis, By Region, 2018- 2030 (USD Million)

  • 6.1. Regional Market Share Analysis, 2024 & 2030
  • 6.2. Regional Market Dashboard
  • 6.3. Regional Market Snapshot
  • 6.4. Tendonitis Treatment Market Share by Region, 2024 & 2030:
  • 6.5. North America
    • 6.5.1. North America tendonitis treatment market, 2018 - 2030 (USD Million)
    • 6.5.2. U.S.
      • 6.5.2.1. U.S. tendonitis treatment market, 2018 - 2030 (USD Million)
    • 6.5.3. Canada
      • 6.5.3.1. Canada tendonitis treatment market, 2018 - 2030 (USD Million)
    • 6.5.4. Mexico
      • 6.5.4.1. Mexico tendonitis treatment market, 2018 - 2030 (USD Million)
  • 6.6. Europe
    • 6.6.1. Europe tendonitis treatment market, 2018 - 2030 (USD Million)
    • 6.6.2. UK
      • 6.6.2.1. UK tendonitis treatment market, 2018 - 2030 (USD Million)
    • 6.6.3. Germany
      • 6.6.3.1. Germany tendonitis treatment market, 2018 - 2030 (USD Million)
    • 6.6.4. France
      • 6.6.4.1. France tendonitis treatment market, 2018 - 2030 (USD Million)
    • 6.6.5. Italy
      • 6.6.5.1. Italy tendonitis treatment market, 2018 - 2030 (USD Million)
    • 6.6.6. Spain
      • 6.6.6.1. Spain tendonitis treatment market, 2018 - 2030 (USD Million)
    • 6.6.7. Norway
      • 6.6.7.1. Norway tendonitis treatment market, 2018 - 2030 (USD Million)
    • 6.6.8. Sweden
      • 6.6.8.1. Sweden tendonitis treatment market, 2018 - 2030 (USD Million)
    • 6.6.9. Denmark
      • 6.6.9.1. Denmark tendonitis treatment market, 2018 - 2030 (USD Million)
  • 6.7. Asia Pacific
    • 6.7.1. Japan
      • 6.7.1.1. Japan tendonitis treatment market, 2018 - 2030 (USD Million)
    • 6.7.2. China
      • 6.7.2.1. China tendonitis treatment market, 2018 - 2030 (USD Million)
    • 6.7.3. India
      • 6.7.3.1. India tendonitis treatment market, 2018 - 2030 (USD Million)
    • 6.7.4. Australia
      • 6.7.4.1. Australia tendonitis treatment market, 2018 - 2030 (USD Million)
    • 6.7.5. South Korea
      • 6.7.5.1. South Korea tendonitis treatment market, 2018 - 2030 (USD Million)
    • 6.7.6. Thailand
      • 6.7.6.1. Thailand tendonitis treatment market, 2018 - 2030 (USD Million)
  • 6.8. Latin America
    • 6.8.1. Brazil
      • 6.8.1.1. Brazil tendonitis treatment market, 2018 - 2030 (USD Million)
    • 6.8.2. Argentina
      • 6.8.2.1. Argentina tendonitis treatment market, 2018 - 2030 (USD Million)
  • 6.9. MEA
    • 6.9.1. South Africa
      • 6.9.1.1. South Africa tendonitis treatment market, 2018 - 2030 (USD Million)
    • 6.9.2. Saudi Arabia
      • 6.9.2.1. Saudi Arabia tendonitis treatment market, 2018 - 2030 (USD Million)
    • 6.9.3. UAE
      • 6.9.3.1. UAE tendonitis treatment market, 2018 - 2030 (USD Million)
    • 6.9.4. Kuwait
      • 6.9.4.1. Kuwait tendonitis treatment market, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company Categorization
  • 7.3. Company Profiles
    • 7.3.1. Merck and Co., Inc.
      • 7.3.1.1. Company overview
      • 7.3.1.2. Financial performance
      • 7.3.1.3. Product benchmarking
      • 7.3.1.4. Strategic initiatives
    • 7.3.2. Bayer AG
      • 7.3.2.1. Company overview
      • 7.3.2.2. Financial performance
      • 7.3.2.3. Product benchmarking
      • 7.3.2.4. Strategic initiatives
    • 7.3.3. AstraZeneca
      • 7.3.3.1. Company overview
      • 7.3.3.2. Financial performance
      • 7.3.3.3. Product benchmarking
      • 7.3.3.4. Strategic initiatives
    • 7.3.4. Boehringer Ingelheim Pharmaceuticals, Inc.
      • 7.3.4.1. Company overview
      • 7.3.4.2. Financial performance
      • 7.3.4.3. Product benchmarking
      • 7.3.4.4. Strategic initiatives
    • 7.3.5. Abbott
      • 7.3.5.1. Company overview
      • 7.3.5.2. Financial performance
      • 7.3.5.3. Product benchmarking
      • 7.3.5.4. Strategic initiatives
    • 7.3.6. Pfizer
      • 7.3.6.1. Company overview
      • 7.3.6.2. Financial performance
      • 7.3.6.3. Product benchmarking
      • 7.3.6.4. Strategic initiatives
    • 7.3.7. GlaxoSmithKline PLC
      • 7.3.7.1. Company overview
      • 7.3.7.2. Financial performance
      • 7.3.7.3. Product benchmarking
      • 7.3.7.4. Strategic initiatives
    • 7.3.8. Almatica Pharma, Inc.
      • 7.3.8.1. Company overview
      • 7.3.8.2. Financial performance
      • 7.3.8.3. Product benchmarking
      • 7.3.8.4. Strategic initiatives
    • 7.3.9. Teva Pharmaceuticals Industries
      • 7.3.9.1. Company overview
      • 7.3.9.2. Financial performance
      • 7.3.9.3. Product benchmarking
      • 7.3.9.4. Strategic initiatives